Pneumocystis jirovecii pneumonia in Latin America. A public health problem?

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 6, 2013, Pages 565-570

  Calderón, Enrique J ^a   De Armas, Yaxsier ^b   Panizo, Maria Mercedes ^c   Wissmann, Gustavo ^d  

^a CSIC   (Spain)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^c Instituto Nacional de Higiene Rafael Rangel   (Venezuela)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

epidemiology; Latin America; Pneumocystis jirovecii; Pneumocystis pneumonia

Indexed keywords

ARTICLE; CHEMOPROPHYLAXIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; OPPORTUNISTIC INFECTION; PANDEMIC; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PUBLIC HEALTH PROBLEM; SOUTH AND CENTRAL AMERICA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COINFECTION; DEVELOPING COUNTRIES; FEMALE; HIV; HUMANS; LATIN AMERICA; MALE; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; PUBLIC HEALTH; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84878875673     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.13.41     Document Type: Article

References (58)

1. Calderón Sandubete E, de Armas Rodríguez Y, Capó de Paz V. [Pneumocystis jirovecii: one hundred years of history]. Rev. Cubana Med. Trop. 63(2), 97-116 (2011).
2. Calderón-Sandubete EJ, Varela-Aguilar JM, Medrano-Ortega FJ et al. Historical perspective on Pneumocystis carinii infection. Protist 153(3), 303-310 (2002).
3. Morris A, Lundgren JD, Masur H et al. Current epidemiology of Pneumocystis pneumonia. Emerging Infect. Dis. 10(10), 1713-1720 (2004).
4. Dei-Cas E. Pneumocystis infections: the iceberg? Med. Mycol. 38(Suppl. 1), 23-32 (2000).
5. Weverling GJ, Mocroft A, Ledergerber B et al. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet 353(9161), 1293-1298 (1999).
6. Buchacz K, Baker RK, Palella FJ Jr et al.; HOPS Investigators. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS 24(10), 1549-1559 (2010).
7. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect. Dis. Clin. North Am. 24(1), 107-138 (2010).
8. Krajicek BJ, Thomas CF Jr, Limper AH. Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin. Chest Med. 30(2), 265-278, vi (2009).
9. De Castro N, Pavie J, Lagrange-Xélot M, Molina JM. [Pneumocystis jiroveci pneumonia in patients with cancer: is it unavoidable?] Rev. Mal. Respir. 24(6), 741-750 (2007).
10. Maini R, Henderson KL, Sheridan EA et al. Increasing Pneumocystis pneumonia, England, UK, 2000-2010. Emerg. Infect. Dis. 19, 386-392 (2013).
11. de Armas Rodríguez Y, Wissmann G, Müller AL et al. Pneumocystis jirovecii pneumonia in developing countries. Parasite 18(3), 219-228 (2011).
12. Mayer KH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36, 70-78 (2003).
13. United Nations Development Programme (UNDP). Regional Human Development Report for Latin America and Caribbean 2010. Acting on the Future: Breaking the Intergenerational Transmission of Inequality. Editorama SA, San José, Costa Rica (2010).
14. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Report on the Global AIDS Epidemic 2012. UNAIDS, Geneva, Switzerland (2012).
15. Pérez E, Toibaro JJ, Losso MH. [HIV patient hospitalization during the pre and post-HAART era]. Medicina (B. Aires) 65, 482-488 (2005).
16. Neres Norberg A, Melo Reis CH, de Carvalho Queiroz MA, Ribeiro PC, Pile E, Wilson de Carvalho R. [Pneumocystis jiroveci pneumonia in patients with HIV infection from hospitals of Baixada Fluminense, Rio de Janeiro, Brazil]. Colomb. Med. 40, 213-217 (2009).
17. Soares VY, Lúcio Filho CE, Carvalho LI, Silva AM, Eulálio KD. Clinical and epidemiological analysis of patients with HIV/AIDS admitted to a reference hospital in the northeast region of Brazil. Rev. Inst. Med. Trop. São Paulo 50(6), 327-332 (2008).
18. Soeiro Ade M, Hovnanian AL, Parra ER, Canzian M, Capelozzi VL. Post-mortem histological pulmonary analysis in patients with HIV/AIDS. Clinics (São Paulo) 63(4), 497-502 (2008).
19. Cury PM, Pulido CF, Furtado VM, da Palma FM. Autopsy findings in AIDS patients from a reference hospital in Brazil: analysis of 92 cases. Pathol. Res. Pract. 199(12), 811-814 (2003).
20. Pereira SA, Rodrigues DB, Correia D, dos Reis MA, Teixeira Vde P. [Identification of infectious agents in the lungs in autopsies of patients with acquired immunodeficiency syndrome]. Rev. Soc. Bras. Med. Trop. 35(6), 635-639 (2002).
21. Santos B, Beck EJ, Peixoto MF. Survival and medical intervention in southern Brazilian AIDS patients. Int. J. STD AIDS 5(4), 279-283 (1994).
22. Weinberg A, Duarte MI. Respiratory complications in Brazilian patients infected with human immunodeficiency virus. Rev. Inst. Med. Trop. São Paulo 35(2), 129-139 (1993).
23. Pérez C, García P, Calvo M et al. [Etiology of pneumonia in chilean HIV-infected adult patients]. Rev. Chilena Infectol. 28(4), 343-348 (2011).
24. Chernilo S, Trujillo S, Kahn M, Paredes M, Echevarría G, Sepúlveda C. [Lung diseases among HIV infected patients admitted to the 'Instituto Nacional del Torax' in Santiago, Chile]. Rev. Med. Chil. 133, 517-524 (2005).
25. Rodiño J, Rincón N, Aguilar YA, Rueda ZV, Herrera M, Vélez LA. [Microscopic diagnosis of Pneumocystis jirovecii pneumonia in bronchoalveolar lavage and oropharyngeal wash samples of immunocompromised patients with pneumonia]. Biomedica 31(2), 222-231 (2011).
26. Arteaga Hernández E, Capó de Paz V, Pérez Fernández-Terán ML. [Opportunistic invasive mycoses in AIDS. An autopsy study of 211 cases.] Rev. Iberoam. Micol. 15(1), 33-35 (1998).
27. Estrada y Martin RM, Molina H, Samayoa B et al. [Characteristics of human immunodeficiency virus infection in the San Juan de Dios General Hospital]. Rev. Col. Med. Cir. Guatem. 2(Suppl.), 26-30 (1992).
28. Villasís-Keever A, Rangel-Frausto MS, Ruiz-Palacios G, Ponce de León-Rosales S. Clinical manifestations and survival trends during the first 12 years of the AIDS epidemic in Mexico. Arch. Med. Res. 32(1), 62-65 (2001).
29. Mohar A, Romo J, Salido F et al. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 6(5), 467-473 (1992).
30. Rodríguez French A, Suárez M, Cornejo MX, de Iglesias MT, Roldán T. [Pneumocistis carinii pneumonia in patients with AIDS at the Saint Thomas Hospital]. Rev. Med. Panama. 21(1-2), 4-10 (1996).
31. Eza D, Cerrillo G, Moore DA et al. Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol. Res. Pract. 202(11), 767-775 (2006).
32. De Jesús-Berríos Y, González S, Santé M. Respiratory pathogens in bronchoalveolar lavage in a Puerto Rican population infected with the human immunodeficiency virus. P. R. Health Sci. J. 24(3), 197-202 (2005).
33. Gomez MA, Fernandez DM, Otero JF, Miranda S, Hunter R. The shape of the HIV/AIDS epidemic in Puerto Rico. Rev. Panam. Salud Publica 7(6), 377-383 (2000).
34. Climent C, DeVinatea ML, Lasala G et al. Geographical pathology profile of AIDS in Puerto Rico: the first decade. Mod. Pathol. 7(6), 647-651 (1994).
35. Panizo MM, Reviákina V, Navas T et al. [Pneumocystosis in Venezuelan patients: epidemiology and diagnosis (2001-2006)]. Rev. Iberoam. Micol. 25(4), 226-231 (2008).
36. Guimarães MD. [Temporal study in AIDS-associated disease in Brazil, 1980-1999]. Cad. Saude Publica. 16(Suppl. 1), 21-36 (2000).
37. Ramos AN Jr, Matida LH, Hearst N, Heukelbach J. Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007. AIDS Res. Ther. 8, 23 (2011).
38. Fallo AA, DobrzanskiNisiewicz W, Sordelli N, Cattaneo MA, Scott G, López EL. Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina. Int. J. Infect. Dis. 6(1), 9-16 (2002).
39. Drut R, Anderson V, Greco MA et al. Opportunistic infections in pediatric HIV infection: a study of 74 autopsy cases from Latin America. The Latin American AIDS Pathology Study Group. Pediatr. Pathol. Lab. Med. 17(4), 569-576 (1997).
40. Radisic M, Lattes R, Chapman JF et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl. Infect. Dis. 5(2), 84-93 (2003).
41. Reis MA, Costa RS, Ferraz AS. Causes of death in renal transplant recipients: a study of 102 autopsies from 1968 to 1991. J. R. Soc. Med. 88(1), 24-27 (1995).
42. Quadrelli SA, Alvarez C, Arce SC et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 18(12), 1053-1060 (2009).
43. Desales AL, Mendez-Navarro J, Méndez?Tovar LJ et al. Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab. J. Crohns. Colitis 6(4), 483-487 (2012).
44. Pizzi T, Diaz M. [Interstitial plasma cell pneumonia. II. Parasitological research of Pneumocystis carinii]. Rev. Chil. Pediatr. 27, 294-299 (1956).
45. Arnello M, Quintana JA, Barraza P. [Febrile neutropenia in children with cancer in a medical center of Santiago, Chile]. Rev. Chil. Infectol. 24, 27-32 (2007).
46. Avilés CL, Silva P, Zubieta M et al. [Cancer, febrile neutropenia and pulmonary images: findings in bronchoalveolar lavage in children]. Rev. Chilena Infectol. 29(3), 329-334 (2012).
47. Friaza V, Morilla R, Respaldiza N, de la Horra C, Calderón EJ. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain. Postgrad. Med. 122(6), 24-28 (2010).
48. Matos O, Esteves F. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite 17(3), 219-232 (2010).
49. Armstrong W, Meshnick S, Kazanjian P. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2(1), 61-67 (2000).
50. Helweg-Larsen J, Benfield TL, Eugen?Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 354(9187), 1347-1351 (1999).
51. Navin TR, Beard CB, Huang L et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358(9281), 545-549 (2001).
52. Takahashi T, Hosoya N, Endo T et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J. Clin. Microbiol. 38(9), 3161-3164 (2000).
53. Rabodonirina M, Vaillant L, Taffé P et al. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Emerging Infect. Dis. 19(1), 21-28; quiz 186 (2013).
54. Crothers K, Beard CB, Turner J et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 19(8), 801-805 (2005).
55. Wissmann G, Alvarez-Martinez MJ, Meshnick SR, Dihel AR, Prolla JC. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients. J. Eukaryot. Microbiol. 53(4), 305-307 (2006).
56. Muñoz C, Zuluaga A, Restrepo A, Tobón A, Cano LE, Gonzalez A. Molecular diagnosis and detection of Pneumocystis jirovecii DHPS and DHFR genotypes in respiratory specimens from Colombian patients. Diagn. Microbiol. Infect. Dis. 72(3), 204-213 (2012).
57. Calderón EJ, Gutiérrez-Rivero S, Durand?Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev. Anti. Infect. Ther. 8(6), 683-701 (2010).
58. Stein CR, Poole C, Kazanjian P, Meshnick SR. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerging Infect. Dis. 10(10), 1760-1765 (2004).